Intracranial hypertension in a newborn treated with quinolone;Hypertension intracranienne chez un nouveau-ne traite par quinolones

Presse Medicale

Volumn 27, Issue 23, 1998, Pages 1140-1142

  Bedu, A ^a   Naar, I ^a   Farnoux, C ^a   Brisse, H ^a   Le Huidoux, P ^a   Aujard, Y ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; 4 QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT; PEFLOXACIN; QUINOLONE DERIVATIVE;

ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; ENTEROBACTER INFECTION; GRAM NEGATIVE SEPSIS; HUMAN; INFANT; INTRACRANIAL HYPERTENSION; NEWBORN DISEASE; PARENTERAL NUTRITION; PREMATURITY; ADULT; BACTEREMIA; CHEMICALLY INDUCED DISORDER; CHILD; MALE; NEWBORN; REMISSION;

4-QUINOLONES; ADULT; ANTI-INFECTIVE AGENTS; BACTEREMIA; CEFTAZIDIME; CHILD; ENTEROBACTERIACEAE INFECTIONS; FLUOROQUINOLONES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTRACRANIAL HYPERTENSION; MALE; PARENTERAL NUTRITION; QUINOLONES; REMISSION, SPONTANEOUS;

EID: 0032572399     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Schaad UB, Salam MA, Aujard Y et al. Use of fluoroquinolones in pediatrics : consensus report of an International Society of Chemotherapy commission. Pediatr Infect Dis J 1995 ; 14:1-9.
2. Aujard Y, Baumann C, Bedu A, Bloch J, Bingen E. Utilisation des quinolones en néonatalogie. In: Les quinolones en pédiatrie, Aujard Y, Cendrel D eds. Flammarion/Médecine-Sciences, Paris 1994:65-9.
3. Dhiravibulya K, Ouvrier R, Johnston I, Procopis P, Antony J. Benign intracranial hypertension in childhood : A review of 23 patients. J Paediatr Child Health 1991 ; 27:304-7.
4. Boréus LO, Sundstrom B, Intracranial hypertension in a child during treatment with nalidixic acid. Br Med J 1967 ; ii:744-5.
5. Stahlmann R. Safety profile of the quinolones. J Antimicrob Chemother 1990 ; 26(suppl. D):31-44.
6. Grenier B. Evaluation de la toxicité des quinolones en pédiatrie. In: Les quinolones en pédiatrie, Aujard Y, Gendrel D eds. Flammarion/Médecine-Sciences, Paris 1994:117-22.
7. Lumbiganon P, Pensgaa K, Sookpranec. Ciprofloxacin in neonates and its possible adverse effect on the teeth. Pediatr Infect Dis J 1991 ; 10:619-20.
8. Pariente-Khayat A, Vauzelle-Kervroedan F, d'Athis P et al. Enquête rétrospective sur l'utilisation des fluoroquinolones en pédiatrie. Arch Pediatr 1998 ; 5:484-8.
9. Winrow AP, Supramaniam G. Benign intracranial hypertension after ciprofloxacin administration. Arch Dis Child 1990 ; 65:1165-6.
10. Martell M, de Ben S, Weinberger M, Beltrami G. Growth and development in preterm infants receiving fluoroquinolones. J Perinat Med 1996 ; 24:287-91.
11. Schaefer C, Amoura-Elefant E, Vial T et al. Pregnancy outcome after prenatal quinolone exposure. Evaluation of a case registry of the European Network of Teratology Information Services (ENTIS). Eur J Obstet Gynecol Reprod Biol 1996 ; 69:83-9.